The man had kidney failure and started dialysis three days a week around the time his pain began. He was sure the dialysis ...

Orphan drug specialist Amicus Therapeutics is paying Dimerix $30 million cash for U.S. rights to the phase 3 prospect DMX-200 ...

Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and ...

Alzheimer's disease plagues South Carolina, with more than 112,00 patients and a high death rate. New blood test analyzers at ...